Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis
Chia Siang Kow, Syed Shahzad Hasan
American Journal of Cardiovascular Drugs (2021) Vol. 22, Iss. 2, pp. 167-181
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Respiratory Tract Infections in Diabetes – Lessons From Tuberculosis and Influenza to Guide Understanding of COVID-19 Severity
Amnah Al-Sayyar, Katina D. Hulme, Ronan Thibaut, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 29
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Stanisław Surma, Maciej Banach, Joanna Lewek
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 38
COVID-19 and metabolic syndrome
Harsha Dissanayake
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101753-101753
Open Access | Times Cited: 14
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID‐19 patients
Laura Andrews, Laurel Goldin, Yan Shen, et al.
Journal of Hospital Medicine (2022) Vol. 17, Iss. 3, pp. 169-175
Open Access | Times Cited: 12
A practical approach for the treatment of post-COVID symptoms
Juliane Heitmann, Julian Kreutz, Sümeya Aldudak, et al.
Herz (2023) Vol. 48, Iss. 3, pp. 243-246
Open Access | Times Cited: 5
An evidence-based debate on epigenetics and immunosenescence in COVID-19
Claudio Napoli, Enrico Coscioni, Ugo Trama, et al.
Current Research in Immunology (2023) Vol. 4, pp. 100069-100069
Open Access | Times Cited: 5
Lipid compartments and lipid metabolism as therapeutic targets against coronavirus
Daniella Cesar-Silva, Filipe S. Pereira‐Dutra, Ana L.M. Giannini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Neutrophil Extracellular Traps: An Emerging Therapeutic Target to Improve Infectious Disease Outcomes
Angela Meier, George Sakoulas, Victor Nizet, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 2, pp. 514-521
Closed Access | Times Cited: 1
In Vitro Evidence of Statins’ Protective Role against COVID-19 Hallmarks
Donatella Fiore, Maria Proto, Silvia Franceschelli, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2123-2123
Open Access | Times Cited: 8
Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19
John G. Rizk, Cachet Wenziger, Diana Tran, et al.
Drugs (2021) Vol. 82, Iss. 1, pp. 43-54
Open Access | Times Cited: 9
Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic
Helen Huang, Keith Sai Kit Leung, Tulika Garg, et al.
Clinical Cardiology (2023) Vol. 46, Iss. 8, pp. 831-844
Open Access | Times Cited: 3
Association of antecedent statin use on 30-day, 60-day and 90-day mortality among Mississippi Medicaid beneficiaries diagnosed with COVID-19
Yiran Rong, Swarnali Goswami, O Eriakha, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e076195-e076195
Open Access | Times Cited: 3
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study
Ippazio Cosimo Antonazzo, Carla Fornari, Davide Rozza, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7492-7492
Open Access | Times Cited: 5
DECODING THE THERAPEUTIC POTENTIAL OF EMPON-EMPON: A BIOINFORMATICS EXPEDITION UNRAVELING MECHANISMS AGAINST COVID-19 AND ATHEROSCLEROSIS
NUR HASANAH, Fadlina Chany Saputri, Alhadi Bustamam, et al.
International Journal of Applied Pharmaceutics (2024), pp. 215-223
Open Access
Statins for the prevention of cardiovascular events associated with avian influenza: the COVID-19 pandemic as a reference
Alpo Vuorio, Bruce Budowle, Frederick J. Raal, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access
Statins for the treatment of COVID-19 patients: an updated meta-analysis of randomized controlled trials
Fatemeh Movahed, Ehsan Heidari, Masoud Dehbozorgi, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Proteomic Profiling of COVID-19 Patients Sera: Differential Expression with Varying Disease Stage and Potential Biomarkers
Iman Dandachi, Ayodele Alaiya, Zakia Shinwari, et al.
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2533-2533
Open Access
Can statins reduce mortality in critically ill COVID-19 patients? A retrospective cohort study
Heba A. Labib, Rania M. Ali, Ayman I. Tharwat
Egyptian Journal of Anaesthesia (2023) Vol. 39, Iss. 1, pp. 107-113
Open Access | Times Cited: 1
Drugs in primary care that may alter COVID-19 risk and severity
Brent Luu, Sampath Jeewantha Wijesinghe, Tarek Kassem, et al.
JAAPA (2023) Vol. 36, Iss. 5, pp. 28-33
Closed Access | Times Cited: 1
Statins and cardiovascular disease outcomes: before and during the COVID-19 pandemic (SCOBAC): meta-analysis and systematic review of large populations
Axel Jusuf, Joue Abraham Trixie, Rian Mourbas, et al.
Jurnal Penyakit Dalam Udayana (2023) Vol. 7, Iss. 1, pp. 11-18
Open Access | Times Cited: 1
Potential role of geranylgeraniol in managing statin-associated muscle symptoms: a COVID-19 related perspective
Barrie Tan, Kok‐Yong Chin
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 1
An Efficient Enantioselective Total Synthesis of Atorvastatin ­Calcium
Jaya Shree Anireddy, Naresh Vempala, Srikanth Reddy Narra, et al.
Synlett (2022) Vol. 34, Iss. 03, pp. 283-287
Closed Access | Times Cited: 1
Statin Therapy in COVID-19: Inhibition of NETosis
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Journal of General Internal Medicine (2022) Vol. 38, Iss. 4, pp. 1077-1077
Open Access | Times Cited: 1
Statins and COVID-19 (Mechanism of Action, Effect on Prognosis)
Joanna Lewek, Stanisław Surma, Maciej Banach
Contemporary cardiology (2022), pp. 285-302
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top